Tirzepatide, a groundbreaking therapy, represents a significant step forward in the treatment of type 2 diabetes and, more recently, weight management. This dual activator acts upon two crucial chemicals: incretin hormone and GIP. Unlike traditional diabetes drugs, Tirzepatide promotes not only insulin secretion when glucose levels are elevated but